News und Analysen
Acadia Healthcare Reports First Quarter 2021 Results and Increases 2021 Guidance
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced financial results for the first quarter ended March 31, 2021.
First Quarter 2021 Results
The Company reported revenue of $551.2
Novocure Reports First Quarter 2021 Financial Results and Provides Company Update
Novocure (NASDAQ: NVCR) today reported financial results for the quarter ended March 31, 2021, highlighting continued commercial strength despite changes in patterns of care in some regions driven
Xencor Doses First Subject in Phase 1 Study of XmAb®564, an Engineered IL-2 Cytokine in Development for Autoimmune Diseases
Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today
Xencor to Host First Quarter 2021 Financial Results Webcast and Conference Call on May 5, 2021
Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today
Premier, Inc. Declares Quarterly Cash Dividend
Premier, Inc. (NASDAQ: PINC), a leading healthcare improvement company, today announced that its Board of Directors declared a cash dividend of $0.19 per share of Class A common stock issued and
Arena Pharmaceuticals Presents Clinician and Patient Reported Outcomes Data from Phase 2b ADVISE Trial Evaluating Etrasimod in Adult Atopic Dermatitis During a Late-Breaking Session at American Academy of Dermatology VMX
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced additional data at a late-breaking session at the American Academy of Dermatology VMX Experience. Etrasimod, a novel investigational drug
Novocure Announces FDA IDE Approval and Steering Committee for KEYNOTE-B36 Trial Evaluating Tumor Treating Fields Together with Pembrolizumab in Non-Small Cell Lung Cancer
Novocure (NASDAQ: NVCR) today announced that the U.S. Food and Drug Administration (FDA) has approved its investigational device exemption (IDE) application to initiate the KEYNOTE-B36 trial
Xencor Presents Data from Multiple Preclinical XmAb® Bispecific Antibody and Cytokine Programs at the AACR Annual Meeting 2021
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced
Novocure Announces 26 Presentations at American Association for Cancer Research (AACR) Annual Meeting 2021 Suggesting Broad Applicability of Tumor Treating Fields
Novocure (NASDAQ: NVCR) today announced 26 presentations on Tumor Treating Fields suggesting broad applicability of Tumor Treating Fields at the American Association for Cancer Research (AACR)
Community Healthcare System Partners with Premier, Inc. to Drive Operational Innovation and High-Quality Patient Care
Community Healthcare System, recognized for high-quality care across Northwest Indiana, has partnered with Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company. Through this new
Premier, Inc. to Report Fiscal 2021 Third-Quarter Results and Host Conference Call on May 4, 2021
Premier, Inc. (NASDAQ: PINC) today announced that it will release financial results for its fiscal 2021 third quarter on Tuesday, May 4, 2021, at approximately 6:30 a.m. ET. The company will also
Novocure to Report First Quarter 2021 Financial Results
Novocure (NASDAQ: NVCR) announced today that it will report financial results for the first quarter 2021 on Thursday, April 29, 2021, before the U.S. financial markets open. Novocure’s management
Acadia Healthcare Forms Joint Venture with Geisinger to Build Two State-of-the-Art Behavioral Health Facilities in Northeastern and Central Pennsylvania
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it has formed a joint venture with Geisinger Health, one of Pennsylvania’s premier, integrated healthcare systems. The new
Acadia Healthcare Forms Joint Venture with Lutheran Health Network of Indiana, LLC to Build Modern Behavioral Health Facility to Serve Fort Wayne Area Communities
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it has formed a joint venture with Lutheran Health Network of Indiana, LLC, one of Indiana’s premier, integrated healthcare
Premier Inc. to Participate in KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum on March 23, 2021
Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, announced today that members of its management team are scheduled to present at the KeyBanc Capital Markets Virtual Life
Xencor to Present Preclinical Data from Four Preclinical XmAb® Bispecific Antibody and Cytokine Programs at the American Association for Cancer Research (AACR) Annual Meeting 2021
Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today
Xencor to Present at the Barclays Global Healthcare Conference
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced
Premier Inc. Acquires Invoice Delivery Services (IDS) to Tech-Enable Critical Supply Chain Purchasing Processes
Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, today acquired substantially all the assets and certain liabilities of Invoice Delivery Services, LP (IDS), a leading provider
Acadia Healthcare Reports Fourth Quarter 2020 Results
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced financial results for the fourth quarter and year ended December 31, 2020.
On January 19, 2021, the Company closed on the sale of
Acadia Healthcare to Participate in Raymond James 42nd Annual Institutional Investors Conference
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in the Raymond James 42nd Annual Institutional Investors Conference, which is being held as a
Novocure Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Company Update
Novocure (NASDAQ: NVCR) today reported financial results for the quarter and full year ended December 31, 2020, highlighting revenue growth and financial strength as well as the advancement of the
Xencor and UCLA Enter Collaboration to Discover and Develop Novel XmAb® Therapeutics
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, and UCLA
Ethisphere® Institute Recognizes Premier Inc. as One of the 2021 World’s Most Ethical Companies® for the 14th Year in a Row
Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, has been named one of the 2021 World’s Most Ethical Companies by the Ethisphere® Institute, a global leader in defining and
Xencor Reports Fourth Quarter and Full Year 2020 Financial Results
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today reported
Premier Inc. to Participate in 10th Annual SVB Leerink Global Healthcare Conference on February 24, 2021
Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, announced today that members of its management team are scheduled to present at the 10th Annual SVB Leerink Global Healthcare